New clinical trial data for Eli Lilly's 'triple-G' drug, retatrutide, indicates that the medication effectively lowers blood sugar and aids in weight loss. However, the results leave open questions regarding the drug's potential cardiovascular benefits, specifically whether it offers heart protection comparable to other established therapies.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.